# Denosumab Administration After Spinal Cord Injury

> **NCT01983475** · PHASE4 · UNKNOWN · sponsor: **James J. Peters Veterans Affairs Medical Center** · enrollment: 24 (estimated)

## Conditions studied

- Osteoporosis
- Spinal Cord Injury

## Interventions

- **DRUG:** Denosumab
- **DRUG:** Placebo (identical Denosumab volume of normal saline)

## Key facts

- **NCT ID:** NCT01983475
- **Lead sponsor:** James J. Peters Veterans Affairs Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2020-05
- **Final completion:** 2020-05
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2019-03-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01983475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01983475, "Denosumab Administration After Spinal Cord Injury". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01983475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*